Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease

Código QR

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease

Yanjun Guo,1,2 Luning Wang,2 Mingwei Zhu,2 Honghong Zhang,3 Yazhuo Hu,3 Zhitao Han,3 Jia Liu,4 Weiqin Zhao,1 Dexin Wang11Department of Neurology, Beijing Friendship Hospital, Capital Medical University, 2Department of Geriatric Neurology, PLA General Hospital, 3Institute of Geriatrics, Chinese PLA G...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Guo YJ, Wang LN, Zhu MW, Zhang HH, Hu YZ, Han ZT, Liu J, Zhao WQ, Wang DX
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Alzheimer's disease alpha synuclein tau protein neurofibrillary tangles histopathology Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/112bc78c04244de19b625adf81f14290
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association between Sleep, Alzheimer’s, and Parkinson’s Disease
por: Sumire Matsumoto, et al.
Publicado: (2021)

Hyperphosphorylation of Tau Due to the Interference of Protein Phosphatase Methylesterase-1 Overexpression by MiR-125b-5p in Melatonin Receptor Knockout Mice
por: Han Zhao, et al.
Publicado: (2021)

Liposome delivery systems for the treatment of Alzheimer’s disease
por: Ross C, et al.
Publicado: (2018)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
por: Rachel Kelly, et al.
Publicado: (2021)

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
por: Hu S, et al.
Publicado: (2020)

Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives
por: Vyronia Vassilakopoulou, et al.
Publicado: (2021)

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
por: Sherif Bayoumy, et al.
Publicado: (2021)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Tian-Sin Fan, et al.
Publicado: (2021)

Lentiviral Vectors Expressing Chimeric NEDD4 Ubiquitin Ligases: An Innovative Approach for Interfering with Alpha-Synuclein Accumulation
por: Stefania Vogiatzis, et al.
Publicado: (2021)

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Moxin Wu, et al.
Publicado: (2021)

Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein
por: Gaoping Lin, et al.
Publicado: (2021)

Simple, Single-Shot Phosphoproteomic Analysis of Heat-Stable Tau Identifies Age-Related Changes in pS235- and pS396-Tau Levels in Non-human Primates
por: Shannon N. Leslie, et al.
Publicado: (2021)

Erratum: Behavioral Abnormalities in Knockout and Humanized Tau Mice
por: Frontiers Production Office
Publicado: (2021)

NMR Studies of Tau Protein in Tauopathies
por: Kristine Kitoka, et al.
Publicado: (2021)

High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
por: Marco J. Russo, et al.
Publicado: (2021)

SERUM MYELOPEROXIDASE, MALONDIALDEHYDE, ALPHA-SYNUCLEIN LEVELS IN PATIENTS WITH EPILEPSY
por: Fatma Şimşek, et al.
Publicado: (2021)

Chronic Exposure to Paraquat Induces Alpha-Synuclein Pathogenic Modifications in <i>Drosophila</i>
por: Jean-Noël Arsac, et al.
Publicado: (2021)

Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates
por: Resnikoff H, et al.
Publicado: (2019)

CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation
por: Lea Elsholz, et al.
Publicado: (2021)

The Bacterial Amyloids Phenol Soluble Modulins from <i>Staphylococcus aureus</i> Catalyze Alpha-Synuclein Aggregation
por: Caroline Haikal, et al.
Publicado: (2021)

To target Tau pathologies, we must embrace and reconstruct their complexities
por: Galina Limorenko, et al.
Publicado: (2021)

The direct and indirect effects of α-synuclein on microtubule stability in the pathogenesis of Parkinson’s disease
por: Carnwath T, et al.
Publicado: (2018)

Effect of superparamagnetic nanoparticles coated with various electric charges on α-synuclein and β-amyloid proteins fibrillation process
por: Javdani N, et al.
Publicado: (2019)

Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration
por: Mantas Ziaunys, et al.
Publicado: (2021)

Differential Effects of Human P301L Tau Expression in Young versus Aged Mice
por: Holly C. Hunsberger, et al.
Publicado: (2021)

MALAT1 Regulated mTOR-Mediated Tau Hyperphosphorylation by Acting as a ceRNA of miR144 in Hippocampus Cells Exposed to High Glucose
por: Lu C, et al.
Publicado: (2021)

Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
por: Edmond Teng, et al.
Publicado: (2021)

Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease
por: Mar Cuadrado-Tejedor, et al.
Publicado: (2021)

The Retinal Posterior Pole in Early Parkinson’s Disease: A Fundus Perimetry and SD-OCT Study
por: Cesareo M, et al.
Publicado: (2021)

Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology
por: Jianfeng Wu, et al.
Publicado: (2021)

Salivary Biomarkers in Alzheimer´s Disease
por: Santos,Gustavo A. A, et al.
Publicado: (2020)

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
por: Chihiro Sato, et al.
Publicado: (2021)

Anti-Aggregative Effect of the Antioxidant DJ-1 on the TPPP/p25-Derived Pathological Associations of Alpha-Synuclein
por: Judit Oláh, et al.
Publicado: (2021)

A Computational Model of the Trans-Synaptic Spread of Pathogenic Tau in Early Alzheimer’s Disease
por: Bashir Sbaiti, et al.
Publicado: (2021)

Missense Mutations Modify the Conformational Ensemble of the α-Synuclein Monomer Which Exhibits a Two-Phase Characteristic
por: Adrien Guzzo, et al.
Publicado: (2021)

Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans
por: Kevin S. Chen, et al.
Publicado: (2021)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Guimei Zhang, et al.
Publicado: (2021)

Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer’s Disease Spectrum
por: Nathalie I. V. Nilsson, et al.
Publicado: (2021)

Neuropathological evidence of body-first vs. brain-first Lewy body disease
por: Per Borghammer, et al.
Publicado: (2021)

Autophagy in α-Synucleinopathies—An Overstrained System
por: Lisa Fellner, et al.
Publicado: (2021)